Impact Factor
3.34
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.04
1,663 total citations
h5-index
32
h5 depth signal
Cited share
62.9%
549 of 873
Total citations
1,663
Citation footprint
Metric signal
2.16
External metric anchor
Self-citation
4.0%
67 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,120
China
568
Japan
231
Italy
225
Canada
186
Citing Fields of Research
Oncology
1,276
Liver & Colon Cancer
886
Digestive Disorders
732
Abdominal Surgery
581
Breast Cancer
569
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
12,978
Articles tracked across the journal lifetime
Indexed publication set
873
549 cited publications
Last 12 months
312
26.0 publications/month
Open access share
27.2%
85 OA publications in the last year
Leading citing country
United States
2,120 citing publications
Leading citing field
Oncology
1,276 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1969-
v1n1, 1969-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Liver & Colon Cancer
Breast Cancer
Digestive Disorders
Musculoskeletal & Nerve Cancer
Issuing & Sponsoring Bodies
Contributor
World Federation of Surgical Oncology Societies
Broad Categories
General Surgery
Neoplasms
Digestive Disorders
Liver & Colon Cancer
Musculoskeletal & Nerve Cancer
Breast Cancer
Reproductive Health
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/jso.70420
Open DOI
Understanding Patient Expectations in Goldilocks‐Based Breast Reconstruction: A Qualitative Study Using the Ottawa Decision Support Framework
Background and Objectives: Goldilocks‐based breast reconstruction (GBR) offers an autologous, implant‐free option for patients seeking breast mound restoration after mastectomy. It is particularly suited for patients with macromastia, pt...
02
DOI 10.1002/jso.70428
Open DOI
Conditional Recurrence‐Free Survival After Hepatectomy for Colorectal Liver Metastases: Time‐Dependent Prognostic Relevance of Liver Metastasis Number
Background and Objectives: Recurrence risk after hepatectomy for colorectal liver metastases (CRLMs) changes during follow‐up, but whether baseline tumor burden remains prognostically relevant with increasing recurrence‐free time is uncl...
03
DOI 10.1002/jso.70415
Open DOI
Hepatic Adenomas in Men: Diagnostic Considerations and Management in the Modern Era
Hepatic adenomas (HAs) are rare benign liver tumors traditionally associated with young women, yet contemporary epidemiologic trends reveal increasing recognition among men. Historically, universal resection in males has been recommended...
04
DOI 10.1002/jso.70430
Open DOI
Combined Incisions in Retroperitoneal Sarcoma Surgery: Safe Access Without Added Morbidity in a Single Center Retrospective Analysis
Introduction: Incisional hernia is a prevalent long‐term complication after open abdominal surgery, with reported rates exceeding 20%–30%. Despite extensive research on abdominal wall failure, evidence regarding incisional hernia after r...
05
DOI 10.1002/jso.70424
Open DOI
Patient‐Reported Outcome Measures in Musculoskeletal Oncology: Current Concepts, Barriers, and the Future
Patient‐reported outcome measures (PROMs) remain underutilized in musculoskeletal oncology, with only 4.9% of tumor‐focused articles incorporating them. This review synthesizes current PROM instruments—including Toronto Extremity Salvage...
06
DOI 10.1002/jso.70425
Open DOI
Association of Adjuvant Radiotherapy De‐Escalation With Outcomes Following Oncoplastic Breast‐Conserving Surgery
Background: Adjuvant radiotherapy (RT) following breast‐conserving surgery reduces local recurrence but can introduce reconstructive morbidity. Although recent trials support the safe omission of RT in selected patients, its impact on su...
07
DOI 10.1002/jso.70423
Open DOI
Missed Care, Missed Opportunities: Health and Economic Impact of Delayed or Forgone Care Among Adults With a History of Gastrointestinal Cancer
Background: Timely medical intervention is critical to achieve optimal outcomes in gastrointestinal (GI) cancers, yet numerous patients experience delayed or forgone (D/F) medical care. This study aimed to evaluate the national impact of...
08
DOI 10.1002/jso.70391
Open DOI
Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Impact of Different Regimens in a Real‐World Population
Introduction: The PRODIGE 24/CCTG PA.6‐ trial has shown an overall survival (OS) up to 55 months in patients treated with (modified) 5‐fluorouracil, leucovorin, irinotecan and oxaliplatin ((m)FOLFIRINOX) chemotherapy after resection of p...
09
DOI 10.1002/jso.70422
Open DOI
Machine Learning‐Based Recurrence and Survival Prediction in a Large Institutional Upper Extremity Soft Tissue Sarcoma Cohort
Background and Objectives: Upper extremity soft tissue sarcomas (UE STS) present unique management challenges; existing prognostic nomograms were developed from mixed anatomic cohorts. This study develops anatomically specific machine le...
10
DOI 10.1002/jso.70419
Open DOI
Repeat Breast Cancer Surgeries After Segmental Mastectomy Meaningfully Increase Long Term Healthcare Costs
Background and Objectives: Among patient with early‐stage breast cancer, breast conservation surgery (BCS) is the most performed surgery, utilized in approximately two‐thirds of patients. While 5‐year overall‐survival rates are strong—ty...
Bibliographical & Catalog Notes
Also issued online.
Official journal of the World Federation of Surgical Oncology Societies, <2010->
(1989)19890816 Notice published Printed on acid-free paper